Immunotherapy for Infectious Diseases
Immunotherapy for Infectious Diseases Immunotherapy for Infectious Diseases
Cytokines, Cytokine Antagonists, and Growth Factors 119 cytokine to its soluble receptor prevents the cytokine from effecting target cell function. An analogous approach toward inhibiting cytokine effect by ligand binding may be used by some viruses that code for receptor-like molecules, e.g., IFN-� (7) and TNF-� (8), thereby inhibiting the effects of these cytokines on the host cell. Receptor Families Cytokine receptors are membrane glycoproteins with a single transmembrane domain and an external amino terminus. The functional receptor can consist of two or more subunits, and these subunits can be shared among different cytokines. This sharing of the receptor subunits among different cytokines may partially explain some of the functional redundancy and costimulation of their production and activity. The receptors can be grouped into four families according to similarities in their DNA or amino acid sequences: the cytokine receptor superfamily, the TNF superfamily, the immunoglobulin superfamily, and the IFN-R family. Most cytokine receptors are members of the cytokine receptor superfamily which is characterized by a conserved amino acid motif in the extracellular portion and in a region proximal to the membrane (9, 10). This superfamily can be divided into three subfamilies according to a shared subunit, i.e., those receptors that share the � chain, the gp 140 � chain, and the gp 130. The receptors in the � chain subfamily consist of three subunits (�, �, �): the �, and � subunits are members of the superfamily and are constitutively expressed on T-cells. Heterodimerization of the �� chains mediates signal transduction. The receptors for IL-13, IL-4, IL-7, IL-9, and IL-15 are members of this subfamily. An example of the sharing of the subunits of the cytokine receptor is the IL-2 receptor: IL-2R� is shared by IL-15, and IL-2R� is a subunit of the receptors for IL-4, IL-7, and IL-9. The subfamily of receptors that share the gp 140 � chain includes the receptors for IL-3, IL-5, and GM-CSF. Receptors in this subfamily have two subunits, with the � chain distinct for each receptor. Both the � and � chains are members of the cytokine receptor superfamily, and signaling is mediated through ligand interactions of the cytoplasmic regions on the shared � chain. The subfamily that shares gp 130 includes receptors for IL-6, IL-11, and IL-12. Formation of homodimers and heterodimers with gp 130 mediates signal transduction by these receptors. The TNF family of receptors includes two distinct receptors that bind TNF, TNFR- I (p75), and TNFR-II (p55). These receptors are homologous and bind both TNF-� and TNF-� with comparable affinity. Interestingly, other receptors in the TNF superfamily do not bind cytokines, e.g., FAS (CD95), which signals apoptosis of thymocytes (11) and CD40 ligand, which signals B-cell survival, proliferation, and switch in the Ig isotype (12). The immunoglobulin superfamily of receptors includes the two receptors for IL-1 (13). Although both receptors bind IL-1 well, the type I receptor is the active moiety, and the type II receptor appears to have minimal activity. However, the type II receptor may be the precursor for soluble IL-1 receptor, which can bind IL-1 after being shed from the membrane. A newly described member of the IL-1 receptor family is the receptor for IL-18, which contains a binding and signaling chain that appears to share signal transduction pathways similar to those of IL-1R (14). Members of the IFN-R family include the receptors for IFN-�, IFN-�, and IL-10, which are distant members of the cytokine receptor superfamily. Investigation into the method of gene transcription through signal transduction from the IFN receptors has become a model for signal transduction by several cytokines, i.e., the Jak-Stat paradigm.
120 Matthews Table 1 Source and Activity of Interleukins and Cytokines with a Major Role in Infection Cytokine Source Activity IL-1�, IL-1� Macrophages, B-cells Stimulates macrophages (increases production of IL-6, TNF-�); enhances PMN adhesion; activates lymphocyte increases IL-2); induces acute-phase protein production; enhances production of platelet-activating factor and nitric oxide IL-2 T-cells Promotes growth and differentiation of T-cells; enhances cytotoxicity of T-cells and NK cells IL-3 T-cells, stem cells Multilineage colony-stimulating factor (stem cells, erythroid, and myeloid) IL-4 T-cells, B-cells, monocytes, Suppresses production of IL-1, TNF, and mast cells, endothelial IFN-� (Th1); upregulates IL-1ra cells production; enhances Th2; promotes Band cytotoxic T-cells; increases IgG1 and IgE production; enhances MHC class II and IgE receptor function IL-5 T-lymphocytes Promotes proliferation and differentiation of B-cells and eosinophils; increases IgA production IL-6 T- and B-cells, NK cells, Activates T- and NK cells; induces monocytes, macrophages, immunoglobulin synthesis by B-cells; fibroblasts induces acute-phase protein synthesis by liver IL-7 Stromal cells of bone Induces proliferation of T- and B-cells marrow IL-8 Most cells including Causes leukocyte chemotaxis, enhances leukocyte and myeloid neutrophil adherence and degranulation precursors, endothelial cells, fibroblasts IL-9 T-cells Prolongs T-cell survival; activates mast cells IL-10 T-cells Inhibits cytokine production by Th1 (TNF-� and IL-1); upregulates IL-1ra production IL-11 Stromal cells of bone Inhibits proinflammatory cytokine marrow production; stimulates osteoclasts and CSF IL-12 Macrophages, dendritic Induces production of TH1 cells; enhances cells, B-cells, mast cells IFN-� production; induces proliferation of NK cells IL-13 T-cells Induces proliferation and differentiation of B-cells; enhances IgE and IgG4 production; inhibits production of proinflammatory cytokines IL-14 T-cells Induces proliferation of activated B-cells; inhibits secretion of immunoglobulin
- Page 79 and 80: 68 Kunert and Katinger Fig. 4. Humo
- Page 81 and 82: 70 Kunert and Katinger remove prote
- Page 83 and 84: 72 Kunert and Katinger Fig. 6. Diff
- Page 85 and 86: 74 Kunert and Katinger persons of a
- Page 87 and 88: 76 Kunert and Katinger that so-call
- Page 89 and 90: 78 Kunert and Katinger whereas sele
- Page 91 and 92: 80 Kunert and Katinger Different pr
- Page 93 and 94: 82 Kunert and Katinger HUMAN/MOUSE
- Page 95 and 96: 84 Kunert and Katinger are expresse
- Page 97 and 98: 86 Kunert and Katinger missing meta
- Page 99 and 100: 88 Kunert and Katinger Fig. 8. Sche
- Page 101 and 102: 90 Kunert and Katinger include a se
- Page 103 and 104: 92 Kunert and Katinger 32. Lee S, e
- Page 105 and 106: 94 Kunert and Katinger 72. Abbs IC,
- Page 107 and 108: 96 Kunert and Katinger 117. Wright
- Page 110 and 111: From: Immunotherapy for Infectious
- Page 112 and 113: Dendritic Cells 101 several organis
- Page 114 and 115: Dendritic Cells 103 tion that infec
- Page 116 and 117: Dendritic Cells 105 chaperones such
- Page 118 and 119: Dendritic Cells 107 CD8� CTLs, th
- Page 120 and 121: Dendritic Cells 109 complete tumor
- Page 122 and 123: Dendritic Cells 111 19. Holland SM,
- Page 124 and 125: Dendritic Cells 113 mouse pneumonit
- Page 126 and 127: Dendritic Cells 115 dendritic cells
- Page 128 and 129: INTRODUCTION Cytokines, Cytokine An
- Page 132 and 133: Cytokines, Cytokine Antagonists, an
- Page 134 and 135: Cytokines, Cytokine Antagonists, an
- Page 136 and 137: Cytokines, Cytokine Antagonists, an
- Page 138 and 139: Cytokines, Cytokine Antagonists, an
- Page 140 and 141: Principles of Vaccine Development F
- Page 142 and 143: Principles of Vaccine Development 1
- Page 144 and 145: Principles of Vaccine Development 1
- Page 146 and 147: Principles of Vaccine Development 1
- Page 148 and 149: Principles of Vaccine Development 1
- Page 150 and 151: Principles of Vaccine Development 1
- Page 152 and 153: Principles of Vaccine Development 1
- Page 154 and 155: Principles of Vaccine Development 1
- Page 156 and 157: Principles of Vaccine Development 1
- Page 158: Principles of Vaccine Development 1
- Page 162 and 163: INTRODUCTION Immunopathogenesis of
- Page 164 and 165: Immunopathogenesis of HIV Disease 1
- Page 166 and 167: Immunopathogenesis of HIV Disease 1
- Page 168 and 169: Immunopathogenesis of HIV Disease 1
- Page 170 and 171: Immunopathogenesis of HIV Disease 1
- Page 172: Immunopathogenesis of HIV Disease 1
- Page 175 and 176: 164 Connick counts ranged from 73 t
- Page 177 and 178: 166 Connick retinitis in an individ
- Page 179 and 180: 168 Connick A novel method of ident
Cytokines, Cytokine Antagonists, and Growth Factors 119<br />
cytokine to its soluble receptor prevents the cytokine from effecting target cell function.<br />
An analogous approach toward inhibiting cytokine effect by ligand binding may<br />
be used by some viruses that code <strong>for</strong> receptor-like molecules, e.g., IFN-� (7) and<br />
TNF-� (8), thereby inhibiting the effects of these cytokines on the host cell.<br />
Receptor Families<br />
Cytokine receptors are membrane glycoproteins with a single transmembrane domain<br />
and an external amino terminus. The functional receptor can consist of two or more<br />
subunits, and these subunits can be shared among different cytokines. This sharing of<br />
the receptor subunits among different cytokines may partially explain some of the functional<br />
redundancy and costimulation of their production and activity. The receptors can<br />
be grouped into four families according to similarities in their DNA or amino acid<br />
sequences: the cytokine receptor superfamily, the TNF superfamily, the immunoglobulin<br />
superfamily, and the IFN-R family.<br />
Most cytokine receptors are members of the cytokine receptor superfamily which is<br />
characterized by a conserved amino acid motif in the extracellular portion and in a<br />
region proximal to the membrane (9, 10). This superfamily can be divided into three<br />
subfamilies according to a shared subunit, i.e., those receptors that share the � chain,<br />
the gp 140 � chain, and the gp 130. The receptors in the � chain subfamily consist of<br />
three subunits (�, �, �): the �, and � subunits are members of the superfamily and are<br />
constitutively expressed on T-cells. Heterodimerization of the �� chains mediates signal<br />
transduction. The receptors <strong>for</strong> IL-13, IL-4, IL-7, IL-9, and IL-15 are members of<br />
this subfamily. An example of the sharing of the subunits of the cytokine receptor is<br />
the IL-2 receptor: IL-2R� is shared by IL-15, and IL-2R� is a subunit of the receptors<br />
<strong>for</strong> IL-4, IL-7, and IL-9. The subfamily of receptors that share the gp 140 � chain<br />
includes the receptors <strong>for</strong> IL-3, IL-5, and GM-CSF. Receptors in this subfamily have<br />
two subunits, with the � chain distinct <strong>for</strong> each receptor. Both the � and � chains are<br />
members of the cytokine receptor superfamily, and signaling is mediated through ligand<br />
interactions of the cytoplasmic regions on the shared � chain. The subfamily that<br />
shares gp 130 includes receptors <strong>for</strong> IL-6, IL-11, and IL-12. Formation of homodimers<br />
and heterodimers with gp 130 mediates signal transduction by these receptors.<br />
The TNF family of receptors includes two distinct receptors that bind TNF, TNFR-<br />
I (p75), and TNFR-II (p55). These receptors are homologous and bind both TNF-� and<br />
TNF-� with comparable affinity. Interestingly, other receptors in the TNF superfamily<br />
do not bind cytokines, e.g., FAS (CD95), which signals apoptosis of thymocytes (11)<br />
and CD40 ligand, which signals B-cell survival, proliferation, and switch in the Ig isotype<br />
(12). The immunoglobulin superfamily of receptors includes the two receptors <strong>for</strong><br />
IL-1 (13). Although both receptors bind IL-1 well, the type I receptor is the active moiety,<br />
and the type II receptor appears to have minimal activity. However, the type II<br />
receptor may be the precursor <strong>for</strong> soluble IL-1 receptor, which can bind IL-1 after<br />
being shed from the membrane. A newly described member of the IL-1 receptor family<br />
is the receptor <strong>for</strong> IL-18, which contains a binding and signaling chain that appears<br />
to share signal transduction pathways similar to those of IL-1R (14). Members of the<br />
IFN-R family include the receptors <strong>for</strong> IFN-�, IFN-�, and IL-10, which are distant<br />
members of the cytokine receptor superfamily. Investigation into the method of gene<br />
transcription through signal transduction from the IFN receptors has become a model<br />
<strong>for</strong> signal transduction by several cytokines, i.e., the Jak-Stat paradigm.